RK-582 for advanced colorectal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a new type of pill called RK-582 that may help block the growth of colorectal cancer cells. It is for people whose cancer has spread and hasn't gotten better with other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have colorectal cancer that has spread to other parts of the body and can't be removed by surgery.
- Standard treatments for this cancer have stopped working or caused severe side effects.
- You have at least one tumor that can be measured by scans (like CT or MRI).
- You can swallow capsules by mouth.
- You do not have a history of certain lung problems, blood clots, or brittle bones (osteoporosis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called RBS2418 for people with advanced colorectal cancer that has spread and is getting worse, even after other treatments have stopped working. The goal is to see if RBS2418 can help control the cancer.
This trial tests a combination of two oral medications for people with advanced colorectal cancer who cannot tolerate stronger chemotherapy. The goal is to see if this gentler approach slows tumor growth and improves quality of life.
This Phase 1/2 trial tests LYL273, a new targeted treatment, for people with metastatic colorectal (colon) cancer that has returned or not responded to standard chemo. It’s designed to see how well the drug can control the cancer and what side effects it causes.
This study tests a combination of precisely targeted radiation (SBRT) with two drugs: fruquintinib (a pill that blocks blood supply to tumors) and antibodies that boost your immune system to fight cancer (PD-1 and CTLA-4 inhibitors). It is for people with advanced colorectal cancer who have already tried two standard chemotherapy treatments.
This trial tests a new drug called LRK-4189, alone or with other treatments, for people with advanced solid tumors that have worsened despite prior therapy. The goal is to see if it is safe, tolerable, and helpful against the cancer.
This study is testing a new drug, SHR-3821, to see if it can help people with advanced colorectal cancer that has stopped responding to previous treatments. The goal is to evaluate how well it works and what the side effects might be, offering a potential new option for patients who have limited alternatives.
Hear when a new Unresectable Colorectal Neoplasm Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.